03/01/2010

"Chinas Bold Step Toward Parity"

Bikash Chatterjee, President & CTO

Chatterjee discusses the factors driving China’s transformation from low-cost manufacturing to more sophisticated quality matters.

DOWNLOAD ARTICLE
03/01/2010

"Achieving Bottom Line Continuous Improvement Value"

Bikash Chatterjee, President & CTO

As the U.S. pharmaceutical and biotechnology markets ebb and flow, one truth cannot be argued: sustainability is the provenance of companies that can adapt to the new marketplace and deliver on business performance.

DOWNLOAD ARTICLE
01/01/2010

"Pharma’s Tenuous Commitment to Lean"

Bikash Chatterjee, President & CTO

There is an old saying that “change is inevitable… adapting to change is unavoidable; it’show you do it that sets you together or apart.”1 Looking closely at how we have developed products, defined quality assurance and demonstrated regulatory compliance, the last five
years have been remarkable in terms of coping with change.

DOWNLOAD ARTICLE
12/01/2009

"The China Quality Challenge"

Bikash Chatterjee, President & CTO

After a recent trip to China, I returned more impressed than ever with the rapid level of development within the major markets there. The maturity of the infrastructure in place, ready to support global commerce, was something I was not expecting.

DOWNLOAD ARTICLE
12/01/2009

"Pharmatechs Chatterjee: Drug Manufacturing in The Future"

Bikash Chatterjee, President & CTO

It is an interesting proposition: define what drug manufacturing will look like 20 years from now. There has never been a time when the portent for change has been so imminent.

DOWNLOAD ARTICLE
10/01/2009

"Extending the Visual Factory to the Global Marketplace"

Bikash Chatterjee, President & CTO

Its time to move the Visual Factory from the shop floor to the boardroom.

DOWNLOAD ARTICLE
06/01/2009

"Process Validation Guidance: Light at the End of the Tunnel"

Bikash Chatterjee, President & CTO

Those who embrace the new process validation guidance may separate themselves from those who do not.

DOWNLOAD ARTICLE
10/01/2008

"Preparedness for Pandemic Flu Outbreak: A Case for Business Continuity and Technology-Transfer Planning"

Bikash Chatterjee, President & CTO

Biopharmaceutical companies should come together to create an efficient business continuity plan that would be effective in a pandemic.

DOWNLOAD ARTICLE